Pratik Jaluria is the Executive Director of the Process Development & Manufacturing group at Adverum Biotechnologies, Inc. In this role, he leads a department of scientists developing and transferring the manufacturing process for Adverum’s AAV-based gene therapies. Prior to this position, he worked for several organizations focused on bringing biologics to market for a variety of serious and life-threatening diseases. Earlier in his career, Pratik worked in vaccine development focusing on novel therapies for infectious diseases. Dr. Jaluria received a Ph.D. in Biomolecular Engineering from Johns Hopkins University and B.S. in Biochemical Engineering from Rutgers University. In addition, Dr. Jaluria was awarded an Intramural Training Fellowship allowing him to conduct research at the National Institutes of Health, where he studied modulating cellular properties including growth, adhesion, and adaptation with the use of bioinformatics tools. Dr. Jaluria is the author of numerous peer-reviewed journal articles and other publications. In addition, he is a co-inventor on several patents relating to targeted gene expression and manufacturing processes.